🔗 Share this article

The prestigious award in medical science was awarded for revolutionary discoveries that clarify how the body's defense network targets dangerous pathogens while sparing the healthy tissues.

A trio of esteemed researchers—from Japan Shimon Sakaguchi and American experts Mary Brunkow and Dr. Ramsdell—received this honor.

Their research identified unique "security guards" within the immune system that remove rogue defense cells capable of attacking the body.

These discoveries are now paving the way for innovative treatments for autoimmune diseases and malignancies.

These laureates will share a monetary award worth 11m SEK.

Decisive Discoveries

"The research has been essential for understanding how the immune system functions and the reason we do not all develop serious self-attack conditions," stated the chair of the award panel.

The team's research address a core question: In what way does the immune system defend us from numerous invaders while keeping our healthy cells intact?

Our immune system employs immune cells that search for indicators of infection, including pathogens and germs it has not met before.

Such cells utilize detectors—known as recognition units—that are produced by chance in a vast number of variations.

This provides the immune system the capacity to combat a wide array of invaders, but the unpredictability of the process unavoidably creates white blood cells that can target the host.

Protectors of the Body

Researchers previously knew that some of these problematic defense cells were eliminated in the thymus—where immune cells develop.

This year's Nobel Prize recognizes the identification of regulatory T-cells—known as the body's "security guards"—which travel through the system to neutralize any immune cells that assault the healthy cells.

We know that this mechanism malfunctions in self-attack conditions such as juvenile diabetes, MS, and RA.

The prize committee stated, "These discoveries have laid the foundation for a novel area of investigation and spurred the creation of new treatments, for example for cancer and immune disorders."

In malignancies, T-regs prevent the system from attacking the growth, so research are focused on reducing their numbers.

For self-attack disorders, trials are exploring increasing regulatory T-cells so the organism is not under attack. A comparable method could also be effective in minimizing the risks of transplanted organ rejection.

Pioneering Experiments

Prof Shimon Sakaguchi, from Osaka University, performed tests on rodents that had their immune gland removed, leading to self-attack conditions.

The researcher demonstrated that introducing defense cells from other animals could stop the disease—suggesting there was a system for blocking immune cells from harming the body.

Dr. Brunkow, affiliated with the a research center in a US city, and Dr. Ramsdell, now at a biotech firm in San Francisco, were studying an genetic autoimmune disease in rodents and people that resulted in the discovery of a gene vital for how regulatory T-cells operate.

"The pioneering work has revealed how the body's defenses is controlled by regulatory T cells, stopping it from mistakenly targeting the body's own tissues," commented a prominent physiology expert.

"The work is a striking illustration of how basic biological research can have far-reaching implications for human health."